- Home
- NVAX vs NMM Comparison
NVAX vs NMM Comparison
Compare NVAX & NMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- NMM
- Stock Information
- Founded
- NVAX 1987
- NMM 2007
- Country
- NVAX United States
- NMM Monaco
- Employees
- NVAX N/A
- NMM N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- NMM Marine Transportation
- Sector
- NVAX Health Care
- NMM Consumer Discretionary
- Exchange
- NVAX Nasdaq
- NMM Nasdaq
- Market Cap
- NVAX 1.4B
- NMM 1.3B
- IPO Year
- NVAX 1995
- NMM 2007
- Fundamental
- Price
- NVAX $8.38
- NMM $43.51
- Analyst Decision
- NVAX Buy
- NMM Strong Buy
- Analyst Count
- NVAX 6
- NMM 1
- Target Price
- NVAX $17.83
- NMM $80.00
- AVG Volume (30 Days)
- NVAX 4.8M
- NMM 139.0K
- Earning Date
- NVAX 02-26-2025
- NMM 02-11-2025
- Dividend Yield
- NVAX N/A
- NMM 0.46%
- EPS Growth
- NVAX N/A
- NMM N/A
- EPS
- NVAX N/A
- NMM 13.27
- Revenue
- NVAX $885,193,000.00
- NMM $1,328,798,000.00
- Revenue This Year
- NVAX N/A
- NMM N/A
- Revenue Next Year
- NVAX N/A
- NMM $15.39
- P/E Ratio
- NVAX N/A
- NMM $3.19
- Revenue Growth
- NVAX N/A
- NMM N/A
- 52 Week Low
- NVAX $3.60
- NMM $27.80
- 52 Week High
- NVAX $23.86
- NMM $65.89
- Technical
- Relative Strength Index (RSI)
- NVAX 45.04
- NMM 43.83
- Support Level
- NVAX $8.30
- NMM $40.70
- Resistance Level
- NVAX $9.77
- NMM $42.81
- Average True Range (ATR)
- NVAX 0.56
- NMM 1.33
- MACD
- NVAX -0.06
- NMM 0.10
- Stochastic Oscillator
- NVAX 12.67
- NMM 32.31
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through chartering of vessels, voyage contracts. Geographically, it generates majority revenue from Asia.